Immunohistochemical detection of the lymphatic marker podoplanin in diverse types of human cancer cells using a novel antibody

International Journal of Oncology

Volumn 31, Issue 3, 2007, Pages 501-508

  Kono, Tomoya ^a   Shimoda, Masayuki ^a   Takahashi, Meiko ^a   Matsumoto, Kyoichi ^b   Yoshimoto, Takanobu ^a   Mizutani, Mika ^a   Tabata, Chiharu ^a   Okoshi, Kae ^a   Wada, Hiromi ^a   Kubo, Hajime ^a  

^a KYOTO UNIVERSITY   (Japan)

^b SRL INC   (Japan)

Author keywords

Antibody; Immunohistochemistry; Lymphatic marker; Podoplanin; Tissue microarray

Indexed keywords

MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 7B10; PDPN PROTEIN, HUMAN; TUMOR ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; CELL STRAIN 3T3; CHEMISTRY; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY; LUNG; LYMPH NODE; LYMPH NODE METASTASIS; METABOLISM; METASTASIS; METHODOLOGY; MOUSE; PATHOLOGY; PODOCYTE; THROMBOCYTE AGGREGATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY; LUNG; LYMPH NODES; LYMPHATIC METASTASIS; MEMBRANE GLYCOPROTEINS; MICE; NEOPLASM METASTASIS; NIH 3T3 CELLS; PLATELET AGGREGATION; PODOCYTES; TUMOR MARKERS, BIOLOGICAL;

EID: 38449109066     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.31.3.501     Document Type: Article

References (30)

1. Breiteneder-Geleff S, Soleiman A, Kowalski H, et al: Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am J Pathol 154: 385-394, 1999. (Pubitemid 29094089)
2. Saharinen P, Tammela T, Karkkainen MJ, et al: Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation. Trends Immunol 25: 387-395, 2004.
3. Ramirez MI, Millien G, Hinds A, et al: T1alpha, a lung type I cell differentiation gene, is required for normal lung cell proliferation and alveolus formation at birth. Dev Biol 256: 61-72, 2003. (Pubitemid 36332205)
4. Schacht V, Ramirez MI, Hong YK, et al: T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. EMBO J 22: 3546-3556, 2003. (Pubitemid 36898332)
5. He Y, Rajantie I, Ilmonen M, et al: Preexisting lymphatic endothelium but not endothelial progenitor cells are essential for tumor lymphangiogenesis and lymphatic metastasis. Cancer Res 64: 3737-3740, 2004. (Pubitemid 38697279)
6. Takahashi M, Yoshimoto T and Kubo H: Molecular mechanisms of lymphangiogenesis. Int J Hematol 80: 29-34, 2004.
7. Shimizu K, Kubo H, Yamaguchi K, et al: Suppression of VEGFR-3 signaling inhibits lymph node metastasis in gastric cancer. Cancer Sci 95: 328-333, 2004. (Pubitemid 38519473)
8. Honn KV, Tang DG and Crissman JD: Platelets and cancer metastasis: a causal relationship? Cancer Metastasis Rev 11: 325-351, 1992.
9. Oleksowicz L and Dutcher JP: Adhesive receptors expressed by tumor cells and platelets: novel targets for therapeutic antimetastatic strategies. Med Oncol 12: 95-102, 1995.
10. Tsuruo T, Yamori T, Naganuma K, et al: Characterization of metastatic clones derived from a metastatic variant of mouse colon adenocarcinoma 26. Cancer Res 43: 5437-5442, 1983. (Pubitemid 14230162)
11. Watanabe M, Okochi E, Sugimoto Y, et al: Identification of a platelet-aggregating factor of murine colon adenocarcinoma 26: Mr 44,000 membrane protein as determined by monoclonal antibodies. Cancer Res 48: 6411-6416, 1988.
12. Watanabe M, Sugimoto Y and Tsuruo T: Expression of a Mr 41,000 glycoprotein associated with thrombin-independent platelet aggregation in high metastatic variants of murine B16 melanoma. Cancer Res 50: 6657-6662, 1990.
13. Sugimoto Y, Watanabe M, Oh-Hara T, et al: Suppression of experimental lung colonization of a metastatic variant of murine colon adenocarcinoma 26 by a monoclonal antibody 8F11 inhibiting tumor cell-induced platelet aggregation. Cancer Res 51: 921-925, 1991.
14. Toyoshima M, Nakajima M, Yamori T, et al: Purification and characterization of the platelet-aggregating sialoglycoprotein gp44 expressed by highly metastatic variant cells of mouse colon adenocarcinoma 26. Cancer Res 55: 767-773, 1995.
15. Kato Y, Fujita N, Kunita A, et al: Molecular identification of Aggrus/T1alpha as a platelet aggregation-inducing factor expressed in colorectal tumors. J Biol Chem 278: 51599-51605, 2003.
16. Kato Y, Sasagawa I, Kaneko M, et al: Aggrus: a diagnostic marker that distinguishes seminoma from embryonal carcinoma in testicular germ cell tumors. Oncogene 23: 8552-8556, 2004. (Pubitemid 39540806)
17. Ordonez NG: D2-40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma. Hum Pathol 36: 372-380, 2005.
18. Kato Y, Kaneko M, Sata M, et al: Enhanced expression of Aggrus (T1alpha/podoplanin), a platelet-aggregation-inducing factor in lung squamous cell carcinoma. Tumour Biol 26: 195-200, 2005.
19. Schacht V, Dadras SS, Johnson LA, et al: Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. Am J Pathol 166: 913-921, 2005.
20. Kubo H, Fujiwara T, Jussila L, et al: Involvement of vascular endothelial growth factor receptor-3 in maintenance of integrity of endothelial cell lining during tumor angiogenesis. Blood 96: 546-553, 2000.
21. Kubo H, Cao R, Brakenhielm E, et al: Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea. Proc Natl Acad Sci USA 99: 8868-8873, 2002. (Pubitemid 34693650)
22. Mouta Carreira C, Nasser SM, Di Tomaso E, et al: LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis. Cancer Res 61: 8079-8084, 2001.
23. Morisada T, Oike Y, Yamada Y, et al: Angiopoietin-1 promotes LYVE-1-positive lymphatic vessel formation. Blood 105: 4649-4656, 2005. (Pubitemid 40807284)
24. Breiteneder-Geleff S, Matsui K, Soleiman A, et al: Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis. Am J Pathol 151: 1141-1152, 1997.
25. Nose K, Saito H and Kuroki T: Isolation of a gene sequence induced later by tumor-promoting 12-O-tetradecanoylphorbol- 13-acetate in mouse osteoblastic cells (MC3T3-E1) and expressed constitutively in ras-transformed cells. Cell Growth Differ 1: 511-518, 1990.
26. Boucherot A, Schreiber R, Pavenstadt H, et al: Cloning and expression of the mouse glomerular podoplanin homologue gp38P. Nephrol Dial Transplant 17: 978-984, 2002. (Pubitemid 34746198)
27. Farr AG, Berry ML, Kim A, et al: Characterization and cloning of a novel glycoprotein expressed by stromal cells in T-dependent areas of peripheral lymphoid tissues. J Exp Med 176: 1477-1482, 1992.
28. Banerji S, Ni J, Wang SX, et al: LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 144: 789-801, 1999.
29. Prevo R, Banerji S, Ferguson DJ, et al: Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium. J Biol Chem 276: 19420-19430, 2001.
30. Wigle JT and Oliver G: Prox1 function is required for the development of the murine lymphatic system. Cell 98: 769-778, 1999.